<DOC>
	<DOCNO>NCT02838979</DOCNO>
	<brief_summary>The primary goal propose investigation study impact oral glutamine supplementation muscle mitochondrial endothelial cell function measure mitochondrial energetics vascular function use 31P magnetic resonance spectroscopy optical spectroscopy ( MRS/OS ) among person moderate-severe CKD . The secondary objective describe impact oral glutamine supplementation mitochondrial metabolic profile well inflammatory oxidative stress biomarkers among person chronic kidney disease .</brief_summary>
	<brief_title>Trial Oral Glutamine Mitochondrial Function CKD</brief_title>
	<detailed_description>Chronic kidney disease associate endothelial cell dysfunction muscle waste contribute heighten risk cardiovascular morbidity , mortality functional limitation . Accumulation toxins renal disease may adversely impact endothelial cell nitric oxide bioavailability endothelial Nitric Oxide Synthase ( eNOS ) function consequently heighten oxidative stress suppress mitochondrial biogenesis . To date study investigate potential therapy endothelial muscle dysfunction renal disease target mitochondrial metabolic energetic process . Animal study uremia underscore mitochondrial dysfunction potential precursor endothelial dysfunction . In particular , uremia link proteomic signature indicative metabolic blockage TCA cycle activity fatty acid beta-oxidation . Both process localize mitochondrion may suggest decrease mitochondrial mass function may augur endothelial dysfunction renal disease . Glutamine , anaplerotic agent precursor antioxidant glutathione , potential therapeutic agent bypass metabolic block associate reduce TCA cycle improve antioxidant reserve . The primary goal propose investigation study impact oral glutamine supplementation muscle mitochondrial endothelial cell function measure mitochondrial energetics vascular function use 31P MRS/OS among person moderate-severe CKD . The secondary objective describe impact oral glutamine supplementation mitochondrial metabolic profile well inflammatory oxidative stress biomarkers among person chronic kidney disease .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Adults 20 69 year age Diagnosis moderatesevere CKD , define study estimate glomerular filtration rate ( eGFR ) â‰¤60ml/min/1.73m2 use Chronic Kidney Disease Epidemiology Collaboration equation Ability understand provide inform consent participate study On chronic dialysis Expectation start dialysis within 6 month dialysis access place . Pregnant Have physical immobility ( define wheelchair use ) Insulin dependent diabetes Have implant incompatible MRI Exercise limit cardiopulmonary disease ( e.g . angina , severe heart valve disease , severe COPD , coronary ischemia ) Use anticoagulation ( i.e . warfarin ) Baseline systolic blood pressure &gt; 160 diastolic blood pressure &gt; 100 Inflammatory condition ( e.g . autoimmune disease , HIV ) Thyroid disease Dementia inability consent Cirrhosis , active/chronic hepatitis Use medication interfere muscle mitochondrial function , include steroid , antipsychotic , Coenzyme Q10 , immunosuppresssives , antiviral , muscle relaxant Weight &gt; 300 lbs Personal history family history deep vein thrombosis , pulmonary embolism Active malignancy Patients hospitalize within past 60 day reason . Patients history major atherosclerotic event ( define combine incidence myocardial infarction , urgent targetvessel revascularization , coronary bypass surgery , stroke ) within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Glutamine</keyword>
	<keyword>Chronic Kidney Disease</keyword>
</DOC>